U.S. Orthopedic Regenerative Surgical Products Market Size & Outlook
Related Markets
U.S. orthopedic regenerative surgical products market highlights
- The U.S. orthopedic regenerative surgical products market generated a revenue of USD 1,543.4 million in 2022 and is expected to reach USD 1,983.1 million by 2030.
- The U.S. market is expected to grow at a CAGR of 3.2% from 2023 to 2030.
- In terms of segment, viscosupplements was the largest revenue generating product in 2022.
- Synthetic is the most lucrative product segment registering the fastest growth during the forecast period.
Orthopedic regenerative surgical products market data book summary
| Market revenue in 2022 | USD 1,543.4 million |
| Market revenue in 2030 | USD 1,983.1 million |
| Growth rate | 3.2% (CAGR from 2022 to 2030) |
| Largest segment | Viscosupplements |
| Fastest growing segment | Synthetic |
| Historical data | 2016 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Allografts, Synthetic, Cell-based, Viscosupplements |
| Key market players worldwide | Anika Therapeutics Inc, Vericel Corp, Baxter International Inc, Zimmer Biomet Holdings Inc, Stryker Corp, Smith & Nephew PLC, BioTissue, MiMedx Group Inc, Arthrex, AlloSource, VSY Biotechnology, Aptissen |
Other key industry trends
- In terms of revenue, U.S. accounted for 37.2% of the global orthopedic regenerative surgical products market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. orthopedic regenerative surgical products market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 242.7 million by 2030.
Key Regions: Brazil , UK , Japan , South Africa , Saudi Arabia
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Orthopedic Regenerative Surgical Products Market Scope
Orthopedic Regenerative Surgical Products Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Aptissen | View profile | 11-50 | Plan-les-ouates, Geneve, Switzerland, Europe | http://www.aptissen.com |
| VSY Biotechnology | View profile | 251-500 | Leinfelden-echterdingen, Baden-Wurttemberg, Germany, Europe | https://www.vsybiotechnology.com |
| AlloSource | View profile | 501-1000 | Centennial, Colorado, United States, North America | https://www.allosource.org/ |
| Arthrex | View profile | 5001-10000 | Naples, Florida, United States, North America | https://www.arthrex.com/ |
| BioTissue | View profile | 1-10 | Genève, Geneve, Switzerland, Europe | http://www.biotissue.ch |
| MiMedx Group Inc | View profile | 895 | 1775 West Oak Commons Court, NE, Marietta, GA, United States, 30062 | https://www.mimedx.com |
| Vericel Corp | View profile | 314 | 64 Sidney Street, Cambridge, MA, United States, 02139 | https://www.vcel.com |
| Anika Therapeutics Inc | View profile | 357 | 32 Wiggins Avenue, Bedford, MA, United States, 01730 | https://www.anika.com |
| Smith & Nephew PLC | View profile | 18452 | Hatters Lane, Building 5, Croxley Park, Watford, Hertfordshire, United Kingdom, WD18 8YE | https://www.smith-nephew.com |
| Zimmer Biomet Holdings Inc | View profile | 18000 | 345 East Main Street, Warsaw, IN, United States, 46580 | https://www.zimmerbiomet.com |
| Stryker Corp | View profile | 52000 | 1941 Stryker Way, Portage, MI, United States, 49002 | https://www.stryker.com |
| Baxter International Inc | View profile | 60000 | One Baxter Parkway, Deerfield, IL, United States, 60015 | https://www.baxter.com |
U.S. orthopedic regenerative surgical products market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to orthopedic regenerative surgical products market will help companies and investors design strategic landscapes.
Viscosupplements was the largest segment with a revenue share of 41.38% in 2022. Horizon Databook has segmented the U.S. orthopedic regenerative surgical products market based on allografts, synthetic, cell-based, viscosupplements covering the revenue growth of each sub-segment from 2016 to 2030.
High number of surgical procedures are performed in the country every year. Growing prevalence of lifestyle-related health conditions, rising geriatric population, and favorable government policies are some of the key factors driving the number of surgeries in the country, contributing to market growth.
Furthermore, the U.S. is dominating the market owing to presence of major players such as Stryker, Baxter, and Zimmer Biomet. In February 2020, Anika acquired Arthrosurface to enhance its commercial capabilities, increase revenue, and expand joint preservation & restoration product portfolios, as well as its product pipeline.
While in January 2020, it acquired Parcus Medical a sports medicine implant and instrumentation company thus expanding its soft tissue surgical repair and reconstruction portfolio. These factors support growth of the country’s market.
Reasons to subscribe to U.S. orthopedic regenerative surgical products market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. orthopedic regenerative surgical products market databook
-
Our clientele includes a mix of orthopedic regenerative surgical products market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. orthopedic regenerative surgical products market , including forecasts for subscribers. This country databook contains high-level insights into U.S. orthopedic regenerative surgical products market from 2016 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. orthopedic regenerative surgical products market size, by product, 2016-2030 (US$M)
U.S. Orthopedic Regenerative Surgical Products Market Outlook Share, 2022 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
